SCHEMBL6767997

SCHEMBL6767997

CCCCCCOC(=O)Nc1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.65
NPC1 O15118 8/20 0.65
SMN1; SMN2 Q16637 7/20 0.65
RECQL P46063 1/20 0.65
FAAH O00519 6/20 0.62
HPGD P15428 4/20 0.61
LMNA P02545 3/20 0.61
ALDH1A1 P00352 3/20 0.60
CASP1 P29466 1/20 0.60
KDM4E B2RXH2 1/20 0.60
MAPT P10636 1/20 0.60
MAPK1 P28482 1/20 0.60
MCL1 Q07820 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
EPHX2 P34913 1/20 0.59
TSHR P16473 2/20 0.58
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7995030 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL7653371 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL1834100 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL1837292 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL8076542 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL8600460 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL10599124 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL8600999 0.98 RAB9A (0.67) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL3765824 0.93 RAB9A (0.69) RAB9ANPC1SMN1; SMN2RECQLHPGD
SCHEMBL12411578 0.92 RAB9A (0.69) RAB9ANPC1SMN1; SMN2FAAHHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN claimed
CN-112898184-A Method for continuously synthesizing alicyclic carbamate 河北工业大学 2021-06-04 CN claimed
US-5091556-A Catalytic reacting carbonate with amine ENICHEM SYNTHESIS, S.P.A. (IT) 1992-02-25 US claimed
US-5079383-A With A Methylating Agent Using A Zinc Halide Catalyst MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1992-01-07 US claimed
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-26 US disclosed
EP-4431490-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2024-09-18 EP disclosed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN disclosed
WO-2023080257-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION 旭化成株式会社 2023-05-11 WO disclosed
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN disclosed
CN-109641835-B Method for producing carbamate 国立研究开发法人产业技术综合研究所 2021-07-20 CN disclosed
CN-113024418-A Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2021-06-25 CN disclosed
CN-112898184-A Method for continuously synthesizing alicyclic carbamate 河北工业大学 2021-06-04 CN disclosed
EP-0410684-A2 Method of condensing N-phenylcarbamates ENICHEM SYNTHESIS S.p.A. (IT) 1991-01-30 EP disclosed
EP-0391473-A1 Process for producing carbamates ENICHEM SYNTHESIS S.p.A. (IT) 1990-10-10 EP disclosed
EP-0110732-B1 PROCESS FOR PRODUCING DIPHENYLMETHANE DICARBAMATES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1987-03-11 EP disclosed
EP-0123412-B1 METHOD FOR MANUFACTURE OF DIPHENYLMETHANE DIISOCYANATES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1986-07-09 EP disclosed
US-4552974-A Process for producing diphenylmethane dicarbamates ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-11-12 US disclosed
US-4547322-A Method for manufacture of diphenylmethane diisocyanates ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-10-15 US disclosed
EP-0123412-A1 Method for manufacture of diphenylmethane diisocyanates Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-31 EP disclosed
EP-0110732-A2 Process for producing diphenylmethane dicarbamates Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION IDH3A, CA7, C9 RAB9A 3205/4885NPC1 666/4885SMN1; SMN2 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.